← Leaderboards
Ashish Kumar Pathak
Southern Research Institute
$11,459,907
Attributed
$12,002,896
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$12,002,896 · 4
By mechanism
U19$10,220,097 · 1
R21$1,782,799 · 3
Top collaborators
- Xu Feng2 shared
- Michael John Fuller2 shared
Most similar at Southern Research Institute
Same institution · by research overlap
- Joseph A Maddry$11,761,444
- Rose Hood$20,384,784
- Michael John Fuller$310,420
- Patricia E Noker$6,161,476
Others in their field
Top investigators on “Analog”
- David Heimbrook · Leidos Biomedical Research, Inc.$196,589,777
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Norman Wolmark · Nsabp Foundation, Inc.$51,982,954
- Robert Turner Schooley · University Of Colorado Denver$48,513,949
- Kenneth A Bloom · University Of Nebraska-Lincoln$46,979,168
- John Hobbs · Suny At Stony Brook$41,239,084
Research focus
AnalogDesignDrug KineticsPropertyIn VivoDrug DiscoveryPharmaceutical PreparationsIn VitroResearch Project GrantsBasePharmaceutical ChemistryAutomobile DrivingLeadData SharingData ManagementAnimalsCoronavirus InfectionsCytotoxicityDrug CandidateBiophysical PropertiesComputational BiologyAnti-Viral EfficacyAlphavirusData Storage And Retrieval
Grant awards (12)
Medicinal Chemistry and Lead Development Core - SR$2,759,334
U19 · FY2023 · AI · contact PI
Medicinal Chemistry and Lead Development Core - SR$937,501
U19 · FY2022 · AI · contact PI
Medicinal Chemistry and Lead Development Core - SR$2,240,360
U19 · FY2021 · AI · contact PI
Medicinal Chemistry and Lead Development Core - SR$2,240,361
U19 · FY2020 · AI · contact PI
Development of Targeted Drugs for Osteoporosis$277,279
R21 · FY2020 · AR
Medicinal Chemistry and Lead Development Core - SR$2,042,541
U19 · FY2019 · AI · contact PI
Development of Targeted Drugs for Osteoporosis$187,859
R21 · FY2019 · AR
Synthetic Gypsogenin Saponins as Synergistic Vaccine Adjuvants$315,082
R21 · FY2013 · AI · contact PI
Synthetic Gypsogenin Saponins as Synergistic Vaccine Adjuvants$305,758
R21 · FY2012 · AI · contact PI
New Adjuvant Technologies for a Marburg Virus Vaccine$250,282
R21 · FY2005 · AI
New Adjuvant Technologies for a Marburg Virus Vaccine$25,173
R21 · FY2005 · AI
New Adjuvant Technologies for a Marburg Virus Vaccine$421,366
R21 · FY2004 · AI